Literature DB >> 25583183

Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs.

Akihiro Hashiguchi1, Yujiro Higuchi, Miwa Nomura, Tomonori Nakamura, Hitoshi Arata, Junhui Yuan, Akiko Yoshimura, Yuji Okamoto, Eiji Matsuura, Hiroshi Takashima.   

Abstract

To identify novel mutations causing hereditary motor and sensory neuropathy (HMSN) with pyramidal signs, a variant of Charcot-Marie-Tooth disease (CMT), we screened 28 CMT and related genes in four members of an affected Japanese family. Clinical features included weakness of distal lower limb muscles, foot deformity, and mild sensory loss, then late onset of progressive spasticity. Electrophysiological studies revealed widespread neuropathy. Electron microscopic analysis showed abnormal mitochondria and mitochondrial accumulation in the neurons and Schwann cells. Brain magnetic resonance imaging (MRI) revealed an abnormally thin corpus callosum. In all four, microarrays detected a novel heterozygous missense mutation c.1166A>G (p.Y389C) in the gene encoding the light-chain neurofilament protein (NEFL), indicating that NEFL mutations can result in a HMSN with pyramidal signs phenotype.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  Charcot-Marie-Tooth disease; gene chip array; hereditary motor and sensory neuropathy with pyramidal signs; light-chain neurofilament protein (NEFL); mitochondrial accumulation

Mesh:

Substances:

Year:  2014        PMID: 25583183     DOI: 10.1111/jns.12102

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  13 in total

1.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

2.  Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments.

Authors:  Takaki Taniguchi; Masahiro Ando; Yuji Okamoto; Akiko Yoshimura; Yujiro Higuchi; Akihiro Hashiguchi; Nozomu Matsuda; Mamoru Yamamoto; Eisuke Dohi; Makoto Takahashi; Masanao Yoshino; Taichi Nomura; Masaaki Matsushima; Ichiro Yabe; Yui Sanpei; Hiroyuki Ishiura; Jun Mitsui; Masanori Nakagawa; Shoji Tsuji; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-01-14       Impact factor: 3.172

3.  Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

Authors:  Alejandro Horga; Matilde Laurà; Zane Jaunmuktane; Nivedita U Jerath; Michael A Gonzalez; James M Polke; Roy Poh; Julian C Blake; Yo-Tsen Liu; Sarah Wiethoff; Conceição Bettencourt; Michael Pt Lunn; Hadi Manji; Michael G Hanna; Henry Houlden; Sebastian Brandner; Stephan Züchner; Michael Shy; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-13       Impact factor: 10.154

Review 4.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

5.  Complex hereditary peripheral neuropathies caused by novel variants in mitochondrial-related nuclear genes.

Authors:  Yu Hiramatsu; Yuji Okamoto; Akiko Yoshimura; Jun-Hui Yuan; Masahiro Ando; Yujiro Higuchi; Akihiro Hashiguchi; Eiji Matsuura; Fumihito Nozaki; Tomohiro Kumada; Kei Murayama; Mikiya Suzuki; Yuki Yamamoto; Naoko Matsui; Yoshimichi Miyazaki; Masamitsu Yamaguchi; Youji Suzuki; Jun Mitsui; Hiroyuki Ishiura; Masaki Tanaka; Shinichi Morishita; Ichizo Nishino; Shoji Tsuji; Hiroshi Takashima
Journal:  J Neurol       Date:  2022-03-02       Impact factor: 6.682

6.  Novel de novo POLR3B mutations responsible for demyelinating Charcot-Marie-Tooth disease in Japan.

Authors:  Masahiro Ando; Yujiro Higuchi; Jun-Hui Yuan; Akiko Yoshimura; Ruriko Kitao; Takehiko Morimoto; Takaki Taniguchi; Mika Takeuchi; Jun Takei; Yu Hiramatsu; Yusuke Sakiyama; Akihiro Hashiguchi; Yuji Okamoto; Jun Mitsui; Hiroyuki Ishiura; Shoji Tsuji; Hiroshi Takashima
Journal:  Ann Clin Transl Neurol       Date:  2022-04-28       Impact factor: 5.430

7.  Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-Tooth 2 trigger aggresome formation and neuronal death.

Authors:  Arnaud Jacquier; Cécile Delorme; Edwige Belotti; Raoul Juntas-Morales; Guilhem Solé; Odile Dubourg; Marianne Giroux; Claude-Alain Maurage; Valérie Castellani; Adriana Rebelo; Alexander Abrams; Stephan Züchner; Tanya Stojkovic; Laurent Schaeffer; Philippe Latour
Journal:  Acta Neuropathol Commun       Date:  2017-07-14       Impact factor: 7.801

8.  Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.

Authors:  Masahiro Ando; Akihiro Hashiguchi; Yuji Okamoto; Akiko Yoshimura; Yu Hiramatsu; Junhui Yuan; Yujiro Higuchi; Jun Mitsui; Hiroyuki Ishiura; Ayako Umemura; Koichi Maruyama; Takeshi Matsushige; Shinichi Morishita; Masanori Nakagawa; Shoji Tsuji; Hiroshi Takashima
Journal:  J Peripher Nerv Syst       Date:  2017-07-30       Impact factor: 3.494

9.  Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.

Authors:  Yujiro Higuchi; Akihiro Hashiguchi; Junhui Yuan; Akiko Yoshimura; Jun Mitsui; Hiroyuki Ishiura; Masaki Tanaka; Satoshi Ishihara; Hajime Tanabe; Satoshi Nozuma; Yuji Okamoto; Eiji Matsuura; Ryuichi Ohkubo; Saeko Inamizu; Wataru Shiraishi; Ryo Yamasaki; Yasumasa Ohyagi; Jun-ichi Kira; Yasushi Oya; Hayato Yabe; Noriko Nishikawa; Shinsuke Tobisawa; Nozomu Matsuda; Masayuki Masuda; Chiharu Kugimoto; Kazuhiro Fukushima; Satoshi Yano; Jun Yoshimura; Koichiro Doi; Masanori Nakagawa; Shinichi Morishita; Shoji Tsuji; Hiroshi Takashima
Journal:  Ann Neurol       Date:  2016-03-17       Impact factor: 10.422

10.  Genetic spectrum of Charcot-Marie-Tooth disease associated with myelin protein zero gene variants in Japan.

Authors:  Takaki Taniguchi; Masahiro Ando; Yuji Okamoto; Akiko Yoshimura; Yujiro Higuchi; Akihiro Hashiguchi; Kensuke Shiga; Arisa Hayashida; Taku Hatano; Hiroyuki Ishiura; Jun Mitsui; Nobutaka Hattori; Toshiki Mizuno; Masanori Nakagawa; Shoji Tsuji; Hiroshi Takashima
Journal:  Clin Genet       Date:  2020-11-27       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.